University of Minnesota. Driven to Discover.
Will future research include lab-modified strains that are more transmissible and require tighter safety measures?
A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.
UW calls a recent UK newspaper story biased and largely wrong.
In addition to recent problems with anthrax and smallpox, high-path avian flu has now entered the mix.
Almost half of the board's voting members learned they will soon be replaced.
The NSABB chair says delays in developing a DURC policy have been to blame.
The new policy, which calls on scientists to flag their own experiments as DURC, was met with mixed reviews.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.